Scientists summarize the current knowledge about statins and other agents used as endothelial protectants. They propose further studies using statins for prophylaxis and prevention of end-organ damage related to extensive endothelial dysfunction in hematopoietic stem cell transplantation and chimeric antigen receptor-T cells.
[Blood Reviews]
6445212 MM9UYFKE items 1 apa 0 default asc 1 165957 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-13a84938af438eb023839cf29d4829f4%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MM9UYFKE%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sumransub%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESumransub%2C%20N.%2C%20El%20Jurdi%2C%20N.%2C%20Chiraphapphaiboon%2C%20W.%2C%20%26amp%3B%20Maakaron%2C%20J.%20E.%20%282021%29.%20Putting%20function%20back%20in%20dysfunction%3A%20Endothelial%20diseases%20and%20current%20therapies%20in%20hematopoietic%20stem%20cell%20transplantation%20and%20cellular%20therapies.%20%3Ci%3EBlood%20Reviews%3C%5C%2Fi%3E%2C%20100883.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.blre.2021.100883%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.blre.2021.100883%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DMM9UYFKE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Putting%20function%20back%20in%20dysfunction%3A%20Endothelial%20diseases%20and%20current%20therapies%20in%20hematopoietic%20stem%20cell%20transplantation%20and%20cellular%20therapies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nuttavut%22%2C%22lastName%22%3A%22Sumransub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najla%22%2C%22lastName%22%3A%22El%20Jurdi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wannasiri%22%2C%22lastName%22%3A%22Chiraphapphaiboon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20E.%22%2C%22lastName%22%3A%22Maakaron%22%7D%5D%2C%22abstractNote%22%3A%22Endothelial%20dysfunction%20is%20characterized%20by%20altered%20vascular%20permeability%20and%20prothrombotic%2C%20pro-inflammatory%20phenotypes.%20Endothelial%20dysfunction%20results%20in%20end-organ%20damage%20and%20has%20been%20associated%20with%20diverse%20disease%20pathologies.%20Complications%20observed%20after%20hematopoietic%20stem%20cell%20transplantation%20%28HCT%29%20and%20chimeric%20antigen%20receptor-T%20cell%20%28CAR-T%29%20therapy%20for%20hematologic%20and%20neoplastic%20disorders%20share%20overlapping%20clinical%20manifestations%20and%20there%20is%20increasing%20evidence%20linking%20these%20complications%20to%20endothelial%20dysfunction.%20Despite%20advances%20in%20supportive%20care%20and%20treatments%2C%20end-organ%20toxicity%20remains%20the%20leading%20cause%20of%20mortality.%20A%20new%20strategy%20to%20mitigate%20endothelial%20dysfunction%20could%20lead%20to%20improvement%20of%20clinical%20outcomes%20for%20patients.%20Statins%20have%20demonstrated%20pleiotropic%20effects%20of%20immunomodulatory%20and%20endothelial%20protection%20by%20various%20molecular%20mechanisms.%20Recent%20applications%20in%20immune-mediated%20diseases%20such%20as%20autoimmune%20disorders%2C%20chronic%20inflammatory%20conditions%2C%20and%20graft-versus-host%20disease%20%28GVHD%29%20have%20shown%20promising%20results.%20In%20this%20review%2C%20we%20cover%20the%20mechanisms%20underlying%20endothelial%20dysfunction%20in%20GVHD%20and%20CAR-T%20cell-related%20toxicities.%20We%20summarize%20the%20current%20knowledge%20about%20statins%20and%20other%20agents%20used%20as%20endothelial%20protectants.%20We%20propose%20further%20studies%20using%20statins%20for%20prophylaxis%20and%20prevention%20of%20end-organ%20damage%20related%20to%20extensive%20endothelial%20dysfunction%20in%20HCT%20and%20CAR-T.%22%2C%22date%22%3A%22August%2016%2C%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.blre.2021.100883%22%2C%22ISSN%22%3A%220268-960X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0268960X21000898%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-23T16%3A24%3A53Z%22%7D%7D%5D%7D
Sumransub, N., El Jurdi, N., Chiraphapphaiboon, W., & Maakaron, J. E. (2021). Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies. Blood Reviews, 100883. https://doi.org/10.1016/j.blre.2021.100883 Cite